Stay updated on Pembrolizumab with CyBorD in NDMM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with CyBorD in NDMM Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    In the Record History, a new entry 'Revision: v3.3.3' was added, and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. These updates relate to site/version metadata rather than the study content.
    Difference
    0.2%
    Check dated 2025-12-23T09:46:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.3.2 and removes Revision: v3.3.1 from the list.
    Difference
    0.1%
    Check dated 2025-12-01T16:28:17.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Record History now includes a new revision entry v3.3.1 and removes v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T12:42:51.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Removed the general site-wide notice about a lapse in government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:23:55.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The changes are limited to the record history entries (new version dates and notes) and do not alter core trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:07:08.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Overall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.
    Difference
    12%
    Check dated 2025-10-05T09:11:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with CyBorD in NDMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.